Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on May 14, 2023 11:22am
180 Views
Post# 35447340

RE:RE:RE:AGM was horrible

RE:RE:RE:AGM was horribleI do not think anyone associated with THTX is, or should be, in a comfortable place.

Let's see what happens regarding the directors, especially the two that barely got reelected despite our votes in favor of them. Shareholders sent a clear message and a smaller board is called for based on cost cutting needs alone. I do not believe I supported the status quo in my conversation with the board chair and I think the board are inclined towards decisive action once they have thought it all through. 
houbahop wrote: You are a victime of a highly manipulative and toxic management.

They have obtained from you what they really wanted, aka another year of doing the same thing.
You could have used this opportunity to forced them to walk the talk by taking decisions to bring the company to profitability before year end. Now we all can see this won't happen.

The easy way to send a message without causing to much harm would have been to vote 1 or 2 Directors out like most shareholders have done. Today, it looks like your are the only one protecting the status quo.

This must be a very unconfortable place to be...


<< Previous
Bullboard Posts
Next >>